Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a candy help you sleep better and feel less stressed?

NCT ID NCT07207252

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a special candy containing tea theanine, casein hydrolysate, and saffron extract in 171 Chinese adults aged 20-55 with mild sleep problems. Participants took the candy or a placebo for 28 days, and researchers measured changes in sleep quality, stress, mood, and skin condition. The goal was to see if the candy could improve these areas without medication.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

171 people

The number who actually took part.

Started

Oct 2024

Finished

Dec 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 55 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Sub study 1: Inclusion Criteria: 1. Chinese participants aged 20-55, 2. Mild to moderate sleep disorders (Pittsburgh Sleep Quality Index 5-21), 3. At least 2/3 of the population is under pressure (PSS-10 ≥ 14), 4. No plans to leave Shanghai in the past three months, 5. Have basic Chinese reading comprehension and expression abilities and can independently complete the questionnaire survey, 6. Voluntarily participate in the test and sign an informed consent form, 7. Willing to comply with all evaluation requirements, use the product according to the research protocol, and complete testing and follow-up. During the trial period, do not change the original dietary or skincare habits or use other similar foods, health products, or drugs. Exclusion Criteria: 1. Have used any food, health products, or medication with sleep aid and emotional relief effects within one month before the test, 2. History of tea allergy, 3. History of dairy product allergies, 4. Due to occupational reasons requiring night work or regular changes in working hours, 5. Regularly staying up late within one month before the test (not due to objective reasons or negative emotions, the frequency of staying up late is greater than once per week, such as playing games, watching TV shows, etc.), 6. Intending to become pregnant, or currently pregnant or breastfeeding, 7. Currently treating diseases other than sleep disorders, 8. Using facial and eye skincare products with whitening and spot-removing effects, 9. Has a history of alcohol abuse, 10. There were unhealed skin lesions on the face currently, 11. Have undergone surgical procedures, plastic surgery, or organ transplantation in the past year, 12. Any other health problems or chronic illnesses other than sleep and emotions, 13. Other iatrogenic reasons considered by the expert or professional may influence the evaluation outcome. Sub study 2: Inclusion Criteria: 1. Chinese participants aged 23-55, 2. Right-handedness (not acquired through training), 3. Pressure group (PSS-10 ≥ 14), 4. No plans to leave Shanghai in the past three months, 5. Have basic Chinese reading comprehension and expression abilities, and can independently complete the questionnaire survey, 6. Voluntarily participate in the test and sign an informed consent form, 7. Willing to comply with all evaluation requirements, use the product according to the research protocol, and complete testing. Exclusion Criteria: 1. Have used any food, health products, or medication with sleep aid and emotional relief effects within one month before the test, 2. History of tea allergy, 3. History of dairy product allergies, 4. Unable to effectively induce negative emotions during on-site testing (POMS stress scale and panic scale scores after emotional induction are not higher than baseline), 5. Before testing, any obvious physiological discomfort, including but not limited to fever, hunger, dysmenorrhea, cough, lack of sleep, etc., 6. Frequent insomnia and irregular sleep patterns within a month, 7. Anemia, 8. Abnormal blood sugar and blood pressure, 9. Neurological disorders, 10. Self-reported neurological or emotional disorders such as depression, anxiety, bipolar disorder, and obsessive-compulsive disorder diagnosed by clinical psychiatrists, 11. Alcohol, cigarette addiction, or drug dependence, 12. During drug treatment, ①The individual has systematically taken hypnotic drugs (barbiturates, etc.) or other central nervous system drugs within one year. ②The individual has systematically used anti-anxiety drugs (Benzodiazepines such as diazepam, chlorpromazine, and clonazepam), antiepileptic drugs (such as phenobarbital or clonazepam), antipsychotic, antidepressant, and anti-dementia drugs within one year. 13. Intending to become pregnant, or currently pregnant or breastfeeding, 14. Other iatrogenic reasons considered by the expert or professional may influence the outcome of the evaluation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mild to moderate sleep disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Shanghai China-norm Quality Technical Service Co., Ltd.

    Shanghai, Shanghai Municipality, 200072, China